SCHEMBL4902117

SCHEMBL4902117

CCOC(=O)NC(=S)OCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.44
MGAM O43451 1/20 0.44
SI P14410 1/20 0.44
MGAM2 Q2M2H8 1/20 0.44
ALDH1A1 P00352 6/20 0.42
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
LMNA P02545 1/20 0.40
HSD17B10 Q99714 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MAPT P10636 3/20 0.39
POLB P06746 1/20 0.39
MEN1 O00255 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
KMT2A Q03164 1/20 0.39
ALOX15 P16050 1/20 0.39
CA12 O43570 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7569600 0.88 MGAM (0.42) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL10563632 0.87 HPGD (0.41) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL8967107 0.86 ACHE (0.42) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL5163094 0.84 EPHX1 (0.47) ALDH1A1CYP1A2CYP2C9CYP2C19HPGD
SCHEMBL10564570 0.84 ALDH1A1 (0.45) ALDH1A1MAPTCYP1A2CYP2C9CYP2C19
SCHEMBL5161710 0.84 ALDH1A1 (0.41) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL8966983 0.84 CYP1A2 (0.37) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL10566251 0.84 GAA (0.35) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL5159893 0.84 SMN1; SMN2 (0.42) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL10566438 0.84 ALDH1A1 (0.48) GAAMGAMSIMGAM2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2117718-B1 NOVEL DITHIOCARBAMATE COLLECTORS AND THEIR USE IN THE BENEFICATION OF MINERAL ORE BODIES CYTEC TECH CORP (US) 2017-05-10 EP disclosed
US-8376142-B2 Dithiocarbamate collectors and their use in the beneficiation of mineral ore bodies CYTEC TECHNOLOGY CORP. (US) 2013-02-19 US disclosed
US-20080185317-A1 NOVEL DITHIOCARBAMATE COLLECTORS AND THEIR USE IN THE BENEFICIATION OF MINERAL ORE BODIES CYTEC TECHNOLOGY CORP. 2008-08-07 US disclosed
EP-1716112-A1 INSECTICIDAL AND NEMATICIDAL DIFLUOROALKENE DERIVATIVES E.I. DUPONT DE NEMOURS AND COMPANY (US) 2006-11-02 EP disclosed
WO-2005080327-A1 INSECTICIDAL AND NEMATICIDAL DIFLUOROALKENE DERIVATIVES E.I. DUPONT DE NEMOURS AND COMPANY (US) 2005-09-01 WO disclosed
US-RE32827-E RECOVERY OF METALS AMERICAN CYANAMID (US) 1989-01-10 US disclosed
US-4657688-A FROTH FLOTATION FOR RECOVERING OF METAL VALUES FROM BASE METAL SULFIDE ORES AMERICAN CYANAMID COMPANY (US) 1987-04-14 US disclosed
US-4595493-A Providing aqueous pulp slurry of ore particles, conditioning slurry with frothing agent and metal collector thionocarbamate, frothing, recovering sulfides AMERICAN CYANAMID COMPANY (US) 1986-06-17 US disclosed
US-4584097-A Neutral hydrocarboxycarbonyl thionocarbamate sulfide collectors AMERICAN CYANAMID COMPANY (US) 1986-04-22 US disclosed
US-4226990-A HERBICIDES, FUNGICIDES IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1980-10-07 US disclosed
US-4020076-A INSECTICIDES, NEMATOCIDES, MITICIDES ROUSSEL-UCLAF (FR) 1977-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080185317-A1 NOVEL DITHIOCARBAMATE COLLECTORS AND THEIR USE IN THE BENEFICIATION OF MINERAL ORE BODIES FTH1, FECH, SLC40A1 GAA 2129/4885MGAM 1489/4885SI 4388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.